Perioperative Warming Measures in Cesarean Delivery

NCT05015582 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-05-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the best method for keeping patients warm during cesarean deliveries and the effect of temperature change on the patient and baby

Conditions

  • Hypothermia; Anesthesia
  • Hypothermia, Newborn
  • Hypothermia, Sequela

Interventions

DEVICE

Pre op upper body forced air warming (32˚C)

Use of upper body forced air warming at ambient (32˚C) for at least 30 minutes

DEVICE

Pre op lower body forced air warming (32˚C)

lower body forced air warming at ambient (32˚C) for at least 30 minutes

DEVICE

Pre op fluids (45˚C)

fluids from warmed cabinet set at 45˚C

DEVICE

Intra op upper body forced air warming (32˚C)

Use of upper body forced air warming intra-operative at ambient (32˚C)

DEVICE

Intra op fluids at room temperature

IV fluids at room temperature

DEVICE

Intra op upper body forced air warming at (32˚C)

upper body forced air warming intra-operative at ambient (32˚C)

DEVICE

Intra op upper body forced air warming at (42˚C)

upper body forced air warming intra-operative at ambient (42˚C)

DEVICE

Intra op lower body forced air warming at (32˚C)

Lower body forced air warming intra-operative at ambient (32˚C)

DEVICE

Intra op lower body forced air warming at (42˚C)

Lower body forced air warming intra-operative at ambient (42˚C)

DEVICE

Intra op fluid (42˚C)

IV fluids with hotline fluid warmer set at 42˚C

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Stacy Norrell, MD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2021-12-14
Completion
2021-12-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05015582 on ClinicalTrials.gov